Synthesis of leucine-enkephalin analogs containing α-amino squaric acid

Tetrahedron Letters

Volumn 48, Issue 43, 2007, Pages 7614-7617

  Shinada, Tetsuro ^a   Ishida, Toshikazu ^a   Hayashi, Ken ich ^a   Yoshida, Yasutaka ^a   Shigeri, Yasushi ^b   Ohfune, Yasufumi ^a  

^a Osaka Prefecture University   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Amino acid; Enkephalin; Isostere; Peptide; Squaric acid

Indexed keywords

ALPHA AMINO SQUARIC ACID; DIPEPTIDE DERIVATIVE; GLYCINE; LEUCINE ENKEPHALIN DERIVATIVE; SQUARIC ACID DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONFORMATION; HYDROGENATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN STRUCTURE; SYNTHESIS;

EID: 34548838815     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.08.103     Document Type: Article

References (76)

1. Dujols F.J.M., and Mulliez M.E. J. Org. Chem. 61 (1996) 5648-5649
2. Merricks D., Sammes P.G., Walker E.R.H., Henrick K., and McPartlin M.M. J. Chem. Soc., Perkin Trans. 1 (1991) 2169
3. Gilmore W.F., and Lin H.-J. J. Org. Chem. 43 (1978) 4535
4. Paik S., and White E.H. Tetrahedron 52 (1996) 5303
5. Jinachitra S., and MacLeod A.J. Tetrahedron 35 (1979) 1315
6. Shiba T., Miyoshi K., and Kusumoto S. Bull. Chem. Soc. Jpn. 50 (1977) 254
7. Frankel M., and Moses P. Tetrahedron 9 (1960) 289
8. Neelakantan L., and Hartung W.H. J. Org. Chem. 24 (1959) 1943
9. For recent examples:. Nasopoulou M., Matziari M., Dive V., and Yiotakis A. J. Org. Chem. 71 (2006) 9525
10. Yang K.-W., Golich F.C., Sigdel T.K., and Crowder M.W. Bioorg. Med. Chem. Lett. 15 (2005) 5150
11. Gurulingappa H., Buckhalts P., Kinzler K.W., Vogelstein B., and Khan S.R. Bioorg. Med. Chem. Lett. 14 (2004) 3531
12. Mucha A., Pawelczak M., Hurek J., and Kafarski P. Bioorg. Med. Chem. Lett. 14 (2004) 3113
13. Szabo A., Jaszay Z.M., Toke L., and Petnehazy I. Tetrahedron Lett. 45 (2004) 1991
14. Matziari M., Beau F., Cuniasse P., Dive V., and Yiotakis A. J. Med. Chem. 47 (2004) 325
15. Szabo A., Jazay Z.M., Hegedus L., Toke L., and Petnehazy I. Tetrahedron Lett. 44 (2003) 4603
16. Strancar K., and Gobec S. Synthesis (2004) 359
17. Kaboudin B., and As-habei N. Tetrahedron Lett. 44 (2003) 4243
18. Grembecka J., Mucha A., Cierpicki T., and Kafarski P. J. Med. Chem. 46 (2003) 2641
19. Rushing S.D., and Hammer R.P. J. Am. Chem. Soc. 123 (2001) 4861
20. For reviews:. Kafarski P., and Lejczak B. In: Kukhar V.P., and Hudson H.R. (Eds). Aminophosphonic and Aminophosphinic Acids (2000), John Wiley and Sons, Chichester
21. Kafarski P., and Lejczak B. Curr. Med. Chem.-Anti-Cancer Agents 1 (2001) 301
22. For recent synthetic examples of α-amino phosphonic acids:. Li B., Cai S., Du D., and Xu J. Org. Lett. 9 (2007) 2257
23. Fernandez M.C., Diaz A., Guillin J.J., Blanco O., Ruiz M., and Ojea V. J. Org. Chem. 71 (2006) 6958
24. Xu J., and Gao Y. Synthesis (2006) 783
25. Liu H., Cai S., and Xu J. J. Pept. Sci. 12 (2006) 337
26. Swamy K.C.K., Kumaraswamy S., Kumar K.S., and Muthiah C. Tetrahedron Lett. 46 (2005) 3347
27. Kobayahi S., Kiyohara H., Nakamura Y., and Matsubara R. J. Am. Chem. Soc. 126 (2004) 6558
28. Joly G.D., and Jacobsen E.N. J. Am. Chem. Soc. 126 (2004) 4102
29. Kaboudin B., and Saadati F. Synthesis (2004) 1249
30. Tongcharoensirikul P., Suarez A.I., Voelker T., and Thompson C.M. J. Org. Chem. 69 (2004) 2322
31. de Medina P., Ingrassia L.S., and Mulliez M.E. J. Org. Chem. 68 (2003) 8424
32. Davis F.A., and Prasad K.R. J. Org. Chem. 68 (2003) 7249
33. Chen X., and Wiemer D.F. J. Org. Chem. 68 (2003) 6108
34. Azizi N., and Saidi M. Tetrahedron 59 (2003) 5329
35. Palacios F., Aparicio D., Ochoa de Retana A.M., de los Santos J.M., Gil J.I., and Lopez de Munain R. Tetrahedron: Asymmetry 14 (2003) 689
36. Chandrasekhar S., Narsihmulu C.H., Sultana S.S., Saritha B., and Prakash S.J. Synlett (2003) 505
37. For a review:. Dembitsky V.M., and Srebnik M. Tetrahedron 59 (2003) 579
38. Herr R.J. Bioorg. Med. Chem. 10 (2002) 3379
39. Demko Z.P., and Sharpless K.B. Org. Lett. 4 (2002) 2525
40. Boteju L.W., and Hruby V.J. Tetrahedron Lett. 34 (1993) 1757
41. Zabrocki J., Dunbar Jr. J.B., Marshall K.W., Toth M.V., and Marshall G.R. J. Org. Chem. 57 (1992) 202
42. For selected examples:. Hischmann R., Smith III A.B., Taylor C.M., Benkovic P.A., Taylor S.D., Yager K.M., Sprengeler P.A., and Benkovic S.J. Science 265 (1994) 234
43. Schultz P.G. Angew. Chem., Int. Ed. Engl. 10 (1989) 1283
44. Shultz P.G. Acc. Chem. Res. 22 (1989) 287
45. Bartlett P.A., and Acher F. Bull. Chim. Soc., Fr. (1986) 771
46. Shinada T., Ishida T., and Ohfune Y. Synthesis (2005) 2723
47. Shinada T., Ishida T., and Ohfune Y. Tetrahedron Lett. 45 (2005) 311
48. For reviews:. West R., and Niu J. In: Snyder J.P. (Ed). Nonbenzenoid Aromatics (1969), Academic Press, New York 311
49. West R. Oxocarbons (1980), Academic Press, New York
50. Schmidt A.H. Synthesis (1980) 961
51. Seitz G., and Imming P. Chem. Rev. 2 (1992) 1227
52. Ohno M., and Eguchi S. In: Eguchi S. (Ed). Bioactive Heterocycles I. Topics in Heterocyclic Chemistry Vol. 6 (2006), Springer, Berlin 1-37
53. Recent examples of squaric acid derivatives in bioorganic and medicinal chemistries:. Butera J.A., Jenkins D.J., Lennox J.R., Sheldon J.H., Norton N.W., Warga D., and Argentieri T.M. Bioorg. Med. Chem. Lett. 15 (2005) 2495
54. Lee C.-W., Cao H., Ichiyama K., and Rana T.M. Bioorg. Med. Chem. Lett. 15 (2005) 4243
55. Onaran M.B., Comeau A.B., and Seto C.T. J. Org. Chem. 70 (2005) 10792
56. Smet C., Duckert J.-F., Wieruszeski J.-M., Landrieu I., Buee L., Lippens G., and Deprez B. J. Med. Chem. 48 (2005) 4815
57. Xie J., Comeau A.B., and Seto C.T. Org. Lett. 6 (2004) 83
58. Valgeirsson J., Nielsen E.O., Peters D., Mathiesen C., Kristensen A.S., and Madsen U. J. Med. Chem. 47 (2004) 6948
59. Sun L., Chiu D., Kowal D., Simon R., Smeyne M., Zukin R.S., Oley J., Baudy R., and Lin S. J. Pharm. Exp. Ther. 310 (2004) 563
60. Saksena R., Chernyak A., Poirot E., and Kovac P. Methods Enzymol. 362 (2003) 140
61. Shinada T., Nakagawa Y., Hayashi K., Corzo G., Nakajima T., and Ohfune Y. Amino Acids 24 (2003) 293
62. Lim N.C., Morton M.D., Jenkins H.A., and Bruckner C. J. Org. Chem. 68 (2003) 9233
63. Sato K., Seio K., and Sekine M. J. Am. Chem. Soc. 124 (2002) 12715
64. Porter J.R., Archibald S.C., Childs K., Critchley D., Head J.C., Linsley J.M., Parton T.A.H., Robinson M.K., Shock A., Taylor R.J., Warrellow G.J., Alexander R.P., and Langham B. Bioorg. Med. Chem. Lett. 12 (2002) 1051
65. Shinada T., Hayashi K., Yoshida Y., and Ohfune Y. Synlett (2000) 1506
66. Li H., Xiaohui J., Yun-hua Y., Chongxu F., Romoff T., and Goodman M. Org. Lett. 1 (1999) 91
67. 3H] (5a, 7a, 8b)-(+)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8-yl-benzeneacetamide in a membrane prepared from CHO cells expressing the μ-, δ-, or κ-receptor, respectively. Binding affinities of Leu-Enk and 10a-c [Leu-Enk: μ-receptor (1.8 nM), δ-receptor (0.6 nM), κ-receptors (400 nM); 10a: μ-receptor (>1000 nM), δ-receptor (>1000 nM), κ-receptors (>1000 nM); 10b: μ-receptor (>1000 nM), δ-receptor (420 nM), κ-receptors (>1000 nM); 10c: μ-receptor (350 nM), δ-receptor (970 nM), κ-receptors (>1000 nM)]
68. Rotger M.C., Pina M.N., Frontera A., Martorell G., Ballester P., Deya P.M., and Costa A. J. Org. Chem. 69 (2004) 2302
69. Horikawa M., Shigeri Y., Yumoto N., Yoshikawa S., Nakajima T., and Ohfune Y. Bioorg. Med. Chem. Lett. 8 (1998) 2027
70. Kishore R., and Balaram P. Indian J. Chem. B (1984) 1137
71. Ravi A., Venkataram Prasad B.V., and Balaram P. J. Am. Chem. Soc. 105 (1983) 105
72. Iqbal M., and Balaram P. J. Am. Chem. Soc. 103 (1981) 5548
73. The stability depended on the pH conditions:. Mucha A., Kunert A., Grembecka J., Pawełczak M., and Kafarski P. Eur. J. Med. Chem. 41 (2006) 768
74. Yiotakis A., Lecoq A., Nicolaou A., Labadie J., and Dive V. Biochem. J. 303 (1994) 327
75. Hanson J.E., Kaplan A.P., and Bartlett P.A. Biochemistry 28 (1989) 6294
76. Yamauchi K., Ohtsuki S., and Kinoshita M. J. Org. Chem. 49 (1984) 1158